About Us
Who are we?
We are an innovative business alliance dedicated to building a seamless and scalable wireless ecosystem for wearable technology. We are a multi-component alliance committed to promoting interoperability and improving the user experience in the field of health monitoring.
Our Mission
Our mission is to empower everyone to live healthier, longer, and happier lives.
We achieve this through our advanced, multi-modal, hybrid smartwatch: it can operate independently from a smartphone or function as a complementary device. As the central hub of a personal health ecosystem, it not only connects various IoT devices and aggregates data to a Web3 server equipped with advanced AI analytics, but also monitors vital signs and Traditional Chinese Medicine (TCM) parameters in real time, providing users with data-driven health insights and personalized recommendations to effectively improve their overall well-being.
The scheme, endorsed by the Federation of Hong Kong Watch Trades and Industries Limited, focuses on smart analog watches (SAWs) and aims to promote standardization communication, enhance brand value, and foster collaboration with leading products.
Field Expert Group
We build a foundation of trust in health through professional teams and in-depth collaboration: our core R&D team brings together TCM consultants and technical experts. TCM consultants delve into traditional TCM theory and provide professional support for pulse diagnosis parameter interpretation and customized health recommendations. Technical experts focus on intelligent hardware development and AI algorithm optimization to ensure equipment monitoring accuracy and data analysis capabilities.
Shipping Policy
Professor Zhang Qiming of the China Academy of Chinese Medical Sciences
Zhang Qiming is a second-level professor, doctoral supervisor, and academic leader at the China Academy of Chinese Medical Sciences. He is a "New Century Excellent Talent" designated by the Ministry of Education. He serves as the chairman of the Traditional Chinese Medicine Engineering Branch of the Chinese Society of Biomedical Engineering. He also serves as the chairman of the Traditional Chinese Medicine Academic Research Committee of the China Association for Research and Development of Traditional Chinese Medicine. He leads the Traditional Chinese Medicine Device Professional Group of the Medical Device Classification Technical Committee of the National Medical Products Administration and the Traditional Chinese Medicine Diagnostic Equipment Working Group of the High-end Medical Equipment Innovation Cooperation Platform. He was a member of the expert panel for the Ministry of Science and Technology's 2018 key project, "Active Health and Technological Responses to Aging." He is the project leader for the Ministry of Science and Technology's 2019 key project, "Research on the Modernization of Traditional Chinese Medicine." He advocates for the naturalization of Traditional Chinese Medicine theory and the objective quantification of Traditional Chinese Medicine clinical practice.
Professor Du Jiefu
Professor Du Jiefu, Chief Physician of the Emergency and Critical Care Department and Cardiovascular Medicine Department at the PLA General Hospital (301 Hospital), and Master's Supervisor
Head Physician of the Emergency and Critical Care Department and Cardiovascular Medicine Department at the PLA General Hospital (301 Hospital), and Master's Supervisor. He holds a Ph.D. from the PLA Postgraduate Medical School and a postdoctoral fellowship at the Johns Hopkins University School of Medicine.
With 40 years of clinical experience, he possesses extensive clinical experience in cardiovascular emergency and critical care medicine, specializing in the prevention and treatment of hypertension, coronary heart disease, and various difficult and complex internal medicine conditions.
Professor Chen Jinhua
Professor Chen Jinhua, Assistant Professor, School of Chinese Medicine, Hong Kong Baptist University, and Deputy Director of the Wu Wenzheng Institute of Clinical Chinese Medicine
Professor Chen graduated from Hong Kong Baptist University with a Bachelor's degree in Chinese Medicine and Biomedical Sciences and a Master's degree in Chinese Medicine. He subsequently received a Master's degree in Public Health from the London School of Hygiene and Tropical Diseases, University of London, a Doctorate in Chinese Medicine from Guangzhou University of Chinese Medicine, and a Doctor of Philosophy in Internal Medicine from the University of Hong Kong.
With extensive professional experience, he has served as a research consultant to the World Health Organization, a Chinese medicine practitioner at the Tung Wah Group of Hospitals, an industry expert at KPMG, and a visiting scholar at the Department of Clinical Pharmacy and Pharmacology at the University of Groningen in the Netherlands. He is currently an Assistant Professor at the School of Chinese Medicine, Hong Kong Baptist University, and concurrently serves as Deputy Director of the Wu Wenzheng Institute of Clinical Chinese Medicine and Director of the Master of Chinese Medicine Program.
She has extensive experience in clinical and research fields. Clinically, she specializes in the diagnosis and treatment of infectious diseases, respiratory diseases, metabolic diseases, chronic kidney disease, and other internal medicine conditions. She has conducted research on collaborative Chinese and Western medicine services for diabetic nephropathy at Queen Mary Hospital's specialty and outpatient clinics. In research, she has led the design and execution of numerous clinical trials, cohort studies, and biobanks.
Professor Du Jiefu
Professor Lau Kui-kei, Director of the Stroke Research and Prevention Unit, Department of Medicine, Faculty of Clinical Medicine, University of Hong Kong, Co-founder and Chief Medical Officer of ReMobility
Professor Lau Kui-kei is currently Assistant Dean (Teaching Innovation) of the Li Ka Shing Faculty of Medicine at the University of Hong Kong, Director of the Stroke Research Unit at the University of Hong Kong, and Co-founder of ReMobility. He has published over 170 medical research papers and book chapters on stroke and has developed numerous innovative platforms to improve stroke prevention and overall management. He serves on various local and international stroke-related committees and has received numerous prestigious awards, including the Gold Medal with Special Citation from the Geneva International Exhibition of Inventions and Innovation, the American Heart Association Award for Patient-Oriented or Clinical Hypertension Research, the Generation Aging Leader Award from the Golden Age Foundation, and was named one of Hong Kong's Ten Outstanding Young Persons in 2024.
Professor Xu Jiajie
Professor Jiajie Xu, Director of the East-West Medical Center at the University of California, Los Angeles
Dr. Jiajie Xu is the Wallis Annenberg Professor of Integrative Medicine in the Department of Internal Medicine at the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). He is also the founder and current director of the Center for Integrative Medicine. Professor Xu, a Fellow of the American College of Physicians (FACP), is an internationally renowned clinician, educator, and researcher. He holds board certifications in Internal Medicine and Clinical Pharmacology, with a specialty in geriatrics. He is also a leading authority on Traditional Chinese Medicine and Integrative Medicine and is fluent in both Chinese and English. Since the 1990s, Professor Xu has served as a long-term advisor to the World Health Organization (WHO), providing advice on topics including standardized terminology in Traditional Chinese Medicine (TCM), the appropriate integration of Traditional and Complementary Medicine (T&CM) into healthcare systems and services, and quality regulation of higher education in TCM. He has also provided professional advice to the U.S. Food and Drug Administration (FDA), the National Institutes of Health (NIH), health insurance agencies, pharmaceutical companies, and the media, and has been invited by numerous international universities to serve as Visiting and Honorary Professors.
In December 1993, Professor Xu founded the UCLA Center for Integrative Medicine, one of the earliest integrative medicine centers in the United States. He developed a patient-centered, problem-oriented, holistic care model that emphasizes health promotion, disease prevention, and treatment, and is committed to providing safe, effective, affordable, and accessible care. The center's clinical program receives referrals annually from over 500 physicians within the UCLA Health system, providing integrated treatment options for difficult-to-treat conditions, particularly chronic pain. The center continues to expand in response to the growing demand for holistic care within UCLA and the broader community.
Mr. Ruan Chongwen
Mr. Yuen Chung-man, Director of Tateng Industrial Co., Ltd. and Secretary-General of the Federation of Hong Kong Watch and Clock Trades
Mr. Paul Yuen is a renowned Hong Kong entrepreneur with over two decades of experience developing innovative smart wearable technology. As Director and Director of R&D at Tateng Industrial Co., Ltd., Paul pioneered the integration of traditional watchmaking with cutting-edge smart electronics.
Paul’s vision and leadership are not only reflected in his own business ventures. He is currently the Secretary-General of the Federation of Hong Kong Watch and Clock Trades and a member of the Management Committee of the Hong Kong Productivity Council’s Watches and Clocks Testing Centre (HKWCTC).
Paul firmly believes that 4G smartwatches are key to the IoT revolution, and as such, he's dedicated to fostering cross-industry collaborations between traditional watches and innovative technologies. His unwavering commitment has made him a pioneer in this field, inspiring others to explore the boundless possibilities of smart wearable technology in the ever-evolving digital landscape.